09:56 AM EST, 11/06/2025 (MT Newswires) -- Novavax ( NVAX ) shares were modestly higher in recent Thursday trading after the company raised its 2025 adjusted revenue forecast.

The company reported a Q3 loss early Thursday of $1.25 per diluted share, wider than the loss of $0.76 a year earlier.

Analysts polled by FactSet expected a loss of $1.20.

Revenue for the quarter ended Sept. 30 was $70.4 million, down from $84.5 million a year earlier.

Analysts surveyed by FactSet expected $42.1 million.

For 2025, the company said it now expects adjusted total revenue of $1.04 billion to $1.06 billion, compared with its prior guidance of between $1 billion and $1.05 billion.

Analysts polled by FactSet expect $1.05 billion.

Price: 7.62, Change: -0.07, Percent Change: -0.91